1. Home
  2. BLNK vs ANGO Comparison

BLNK vs ANGO Comparison

Compare BLNK & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blink Charging Co.

BLNK

Blink Charging Co.

HOLD

Current Price

$0.67

Market Cap

89.3M

ML Signal

HOLD

Logo AngioDynamics Inc.

ANGO

AngioDynamics Inc.

HOLD

Current Price

$12.82

Market Cap

530.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLNK
ANGO
Founded
2009
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.3M
530.2M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
BLNK
ANGO
Price
$0.67
$12.82
Analyst Decision
Buy
Strong Buy
Analyst Count
7
3
Target Price
$2.13
$19.33
AVG Volume (30 Days)
8.1M
381.2K
Earning Date
11-06-2025
01-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$106,631,000.00
$300,718,000.00
Revenue This Year
N/A
$8.18
Revenue Next Year
$17.87
$5.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
2.73
52 Week Low
$0.63
$8.27
52 Week High
$2.65
$13.99

Technical Indicators

Market Signals
Indicator
BLNK
ANGO
Relative Strength Index (RSI) 25.27 47.73
Support Level $0.63 $12.76
Resistance Level $0.85 $13.91
Average True Range (ATR) 0.06 0.37
MACD 0.00 -0.10
Stochastic Oscillator 12.24 7.83

Price Performance

Historical Comparison
BLNK
ANGO

About BLNK Blink Charging Co.

Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns a majority of revenue from U.S.A.

About ANGO AngioDynamics Inc.

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Share on Social Networks: